This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Sprout Social (SPT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Sprout Social (SPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SPTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy
by Zacks Equity Research
Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PHRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes ACNB (ACNB) a New Buy Stock
by Zacks Equity Research
ACNB (ACNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ACNBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Rapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RAPTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy
by Zacks Equity Research
Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CLRBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Aldeyra Therapeutics (ALDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ALDXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Amgen (AMGN) a New Buy Stock
by Zacks Equity Research
Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMGNNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Marex Group PLC (MRX) Upgraded to Buy: Here's Why
by Zacks Equity Research
Marex Group PLC (MRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MRXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Zoom (ZM) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Zoom (ZM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZMNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Should GE Aerospace Stock be in Your Portfolio Pre-Q2 Earnings?
by Avisekh Bhattacharjee
GE stock soars 43.8% in three months as Q2 earnings approach, fueled by engine demand and defense strength.
GEPositive Net Change HWMPositive Net Change RTXNegative Net Change
aerospace earnings-outlook
Citigroup (C) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Citigroup (C) delivered earnings and revenue surprises of +21.74% and +3.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CPositive Net Change SCHWNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
PARANegative Net Change ROKUNegative Net Change
earnings-esp earnings-expectations earnings-outlook
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
TROWNegative Net Change PLMRPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
DDOGPositive Net Change METANegative Net Change
earnings-esp earnings-expectations earnings-outlook
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
MAINNegative Net Change MSCINegative Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
MNDYNegative Net Change VZNegative Net Change
earnings-esp earnings-expectations earnings-outlook
How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
MTDRNegative Net Change GEVPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Want Better Returns? Don't Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
NEMNegative Net Change SSRMPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
NOWNegative Net Change ADINegative Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Utilities Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
NRGNegative Net Change NEENegative Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
HUMNegative Net Change INSPNegative Net Change
earnings-esp earnings-expectations earnings-outlook
Wells Fargo (WFC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Wells Fargo (WFC) delivered earnings and revenue surprises of +9.22% and +0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WFCNegative Net Change IBKRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
AngioDynamics (ANGO) delivered earnings and revenue surprises of +76.92% and +7.52%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
ANGONegative Net Change NPCENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
JPMorgan Chase & Co. (JPM) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) delivered earnings and revenue surprises of +9.98% and +2.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JPMNegative Net Change LPLANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Unity Bancorp (UNTY) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Unity Bancorp (UNTY) delivered earnings and revenue surprises of +2.56% and +13.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UNTYNegative Net Change VLYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank